Detalles de la búsqueda
1.
Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities.
Int J Cancer
; 151(2): 240-254, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218560
2.
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.
Carcinogenesis
; 40(2): 303-312, 2019 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30544170
3.
Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab.
Int J Cancer
; 143(9): 2187-2199, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29752717
4.
Drug-Homogeneity Index in Mass-Spectrometry Imaging.
Anal Chem
; 90(22): 13257-13264, 2018 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30359532
5.
Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists.
Angiogenesis
; 20(2): 233-241, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28389777
6.
Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1.
Int J Cancer
; 136(3): 721-9, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24917554
7.
Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.
Am J Pathol
; 184(4): 1050-1061, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24508126
8.
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness.
Cell Death Dis
; 15(5): 370, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38806454
9.
Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment.
Cell Mol Life Sci
; 69(7): 1167-78, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22130514
10.
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.
Cancer Res Commun
; 3(3): 489-500, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36994441
11.
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells.
Oncoimmunology
; 12(1): 2239035, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37538353
12.
Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth.
J Exp Clin Cancer Res
; 42(1): 201, 2023 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37559126
13.
Erratum to: Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists.
Angiogenesis
; 20(2): 243-244, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28488224
14.
Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug delivery.
Histochem Cell Biol
; 137(2): 195-204, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22075565
15.
Endoplasmic reticulum oxidoreductin 1-alpha deficiency and activation of protein translation synergistically impair breast tumour resilience.
Br J Pharmacol
; 179(23): 5180-5195, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35853086
16.
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases.
Mol Cancer Ther
; 21(4): 555-567, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35149547
17.
PGC1α/ß Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.
Cancer Res
; 82(7): 1423-1434, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131872
18.
Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.
J Biol Chem
; 285(12): 8733-42, 2010 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-20056600
19.
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activity.
Matrix Biol
; 103-104: 22-36, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34653669
20.
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling.
J Exp Clin Cancer Res
; 40(1): 319, 2021 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34645505